
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Sexual dysfunctions related to use of antipsychotics: A protocol for a systematic review and meta-analysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A6A68AF2552305A6A60024D38891.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370141/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Sexual dysfunctions related to use of antipsychotics: A protocol for a systematic review and meta-analysis">
<meta name="citation_author" content="Thalia Herder">
<meta name="citation_author_institution" content="Department of Psychiatry, Martini Hospital, Groningen, The Netherlands">
<meta name="citation_author" content="Symen K Spoelstra">
<meta name="citation_author_institution" content="Addiction Care North Netherlands, Groningen, The Netherlands">
<meta name="citation_author_institution" content="NHL Stenden University of Applied Sciences, Leeuwarden, The Netherlands">
<meta name="citation_author" content="Anuschka S Niemeijer">
<meta name="citation_author_institution" content="Scientific Institute, Martini Hospital, Groningen, The Netherlands">
<meta name="citation_author" content="Hendrikus Knegtering">
<meta name="citation_author_institution" content="Lentis Research, Lentis Mental Health Institute, Groningen, The Netherlands">
<meta name="citation_author_institution" content="Department of Psychiatry and Rob Giel Research Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands">
<meta name="citation_author_institution" content="Mental Health Services GGz Drenthe, Department of psychotic illnesses, Assen, The Netherlands">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0329559">
<meta name="citation_doi" content="10.1371/journal.pone.0329559">
<meta name="citation_pmid" content="40839626">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370141/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370141/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370141/pdf/pone.0329559.pdf">
<meta name="description" content="Sexual dysfunctions are a challenging side effect associated with antipsychotic treatment. This protocol outlines a systematic review and meta-analysis to assess the prevalence of overall sexual dysfunction, as well as the specific phases of sexual ...">
<meta name="og:title" content="Sexual dysfunctions related to use of antipsychotics: A protocol for a systematic review and meta-analysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Sexual dysfunctions are a challenging side effect associated with antipsychotic treatment. This protocol outlines a systematic review and meta-analysis to assess the prevalence of overall sexual dysfunction, as well as the specific phases of sexual ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370141/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12370141">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0329559"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0329559.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370141%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12370141/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12370141/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370141/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0329559" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 21;20(8):e0329559. doi: <a href="https://doi.org/10.1371/journal.pone.0329559" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329559</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Sexual dysfunctions related to use of antipsychotics: A protocol for a systematic review and meta-analysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Herder%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Thalia Herder</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Thalia Herder</span></h3>
<div class="p">
<sup>1</sup>Department of Psychiatry, Martini Hospital, Groningen, The Netherlands</div>
<div>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Herder%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thalia Herder</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spoelstra%20SK%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Symen K Spoelstra</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Symen K Spoelstra</span></h3>
<div class="p">
<sup>2</sup>Addiction Care North Netherlands, Groningen, The Netherlands</div>
<div class="p">
<sup>3</sup>NHL Stenden University of Applied Sciences, Leeuwarden, The Netherlands</div>
<div>Conceptualization, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spoelstra%20SK%22%5BAuthor%5D" class="usa-link"><span class="name western">Symen K Spoelstra</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Niemeijer%20AS%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Anuschka S Niemeijer</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Anuschka S Niemeijer</span></h3>
<div class="p">
<sup>4</sup>Scientific Institute, Martini Hospital, Groningen, The Netherlands</div>
<div>Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Niemeijer%20AS%22%5BAuthor%5D" class="usa-link"><span class="name western">Anuschka S Niemeijer</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Knegtering%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Hendrikus Knegtering</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Hendrikus Knegtering</span></h3>
<div class="p">
<sup>5</sup>Lentis Research, Lentis Mental Health Institute, Groningen, The Netherlands</div>
<div class="p">
<sup>6</sup>Department of Psychiatry and Rob Giel Research Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands</div>
<div class="p">
<sup>7</sup>Mental Health Services GGz Drenthe, Department of psychotic illnesses, Assen, The Netherlands</div>
<div>Conceptualization, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Knegtering%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hendrikus Knegtering</span></a>
</div>
</div>
<sup>5,</sup><sup>6,</sup><sup>7</sup>
</div>
<div class="cg p">Editor: <span class="name western">Hidetaka Hamasaki</span><sup>8</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Department of Psychiatry, Martini Hospital, Groningen, The Netherlands</div>
<div id="aff002">
<sup>2</sup>Addiction Care North Netherlands, Groningen, The Netherlands</div>
<div id="aff003">
<sup>3</sup>NHL Stenden University of Applied Sciences, Leeuwarden, The Netherlands</div>
<div id="aff004">
<sup>4</sup>Scientific Institute, Martini Hospital, Groningen, The Netherlands</div>
<div id="aff005">
<sup>5</sup>Lentis Research, Lentis Mental Health Institute, Groningen, The Netherlands</div>
<div id="aff006">
<sup>6</sup>Department of Psychiatry and Rob Giel Research Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands</div>
<div id="aff007">
<sup>7</sup>Mental Health Services GGz Drenthe, Department of psychotic illnesses, Assen, The Netherlands</div>
<div id="edit1">
<sup>8</sup>Japanese Academy of Health and Practice, JAPAN</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>t.herder@mzh.nl</span></p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Thalia Herder</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Symen K Spoelstra</span></strong>: <span class="role">Conceptualization, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Anuschka S Niemeijer</span></strong>: <span class="role">Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization</span>
</div>
<div>
<strong class="contrib"><span class="name western">Hendrikus Knegtering</span></strong>: <span class="role">Conceptualization, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Hidetaka Hamasaki</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 11; Accepted 2025 Jul 17; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Herder et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12370141  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40839626/" class="usa-link">40839626</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec001"><h3 class="pmc_sec_title">Introduction</h3>
<p>Sexual dysfunctions are a challenging side effect associated with antipsychotic treatment. This protocol outlines a systematic review and meta-analysis to assess the prevalence of overall sexual dysfunction, as well as the specific phases of sexual function affected by antipsychotic medications. Additionally, the analysis will explore the relationship between prolactin levels and sexual dysfunction.</p></section><section id="sec002"><h3 class="pmc_sec_title">Methods and analysis</h3>
<p>This protocol has been registered in the database of the International prospective register of systematic reviews (PROSPERO) under the registration number CRD42024573877. We will conduct a systematic search across electronic databases, including PubMed, MEDLINE, PsycINFO, Web of Science, the Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and CINAHL, to identify relevant studies. Studies will be included if they meet predefined inclusion criteria, which include only controlled randomized trials assessing sexual functioning in patients receiving antipsychotic treatment. The antipsychotic medications of interest are amisulpride, aripiprazole, asenapine, brexpiprazole, cariprazine, chlorpromazine, clopenthixol, clozapine, droperidol, flupenthixol, fluphenazine, haloperidol, iloperidone, levomepromazine, loxapine, lurasidone, molindone, olanzapine, paliperidone, penfluridol, perphenazine, perazine, pimozide, prochlorperazine, quetiapine, risperidone, sertindole, sulpiride, thiothixene, thioridazine, trifluoperazine, ziprasidone, zuclopenthixol and zotepine. The primary outcome is the overall prevalence of sexual dysfunction among patients undergoing antipsychotic treatment, while the secondary outcomes include the domains of sexual dysfunction (e.g., desire, arousal, orgasm) and serum prolactin levels. A network meta-analysis (NMA) will be performed using random effects to combine all available evidence for each outcome, aimed to provide a comprehensive ranking of different antipsychotics. NMA will be performed in R within a frequentist paradigm. The Cochrane Risk of Bias tool and RoB 2.0 will be used to assess the risk of bias in studies. We will evaluate the quality of the evidence contributing to network estimates for the primary outcomes using the GRADE framework, and key factors that may affect the observed effects will be analysed for consistency across studies.</p></section></section><section id="sec003"><h2 class="pmc_sec_title">Introduction</h2>
<p>Sexual dysfunction is believed to be highly prevalent among individuals with psychiatric disorders [<a href="#pone.0329559.ref001" class="usa-link" aria-describedby="pone.0329559.ref001">1</a>]. Numerous factors can significantly impact sexual health in patients with mental health disorders, including the disease or disorder itself, comorbidities, stigma or difficulties in engaging in social and sexual relationships [<a href="#pone.0329559.ref001" class="usa-link" aria-describedby="pone.0329559.ref001">1</a>,<a href="#pone.0329559.ref002" class="usa-link" aria-describedby="pone.0329559.ref002">2</a>]. Sexual dysfunction is a clinically significant impairment in sexual desire, arousal, orgasm, or satisfaction, as measured by validated instruments and reported by the patient as causing distress or functional impairment in the context of sexual activity [<a href="#pone.0329559.ref003" class="usa-link" aria-describedby="pone.0329559.ref003">3</a>].</p>
<p>In addition, specific psychotropic medications used to treat these disorders, such as antipsychotics, are known for their detrimental effects on sexual health [<a href="#pone.0329559.ref004" class="usa-link" aria-describedby="pone.0329559.ref004">4</a>]. In clinical practice, antipsychotics have a broad range of applications beyond schizophrenia. Antipsychotics are frequently prescribed for managing various other psychiatric disorders, such as bipolar disorder and major depressive disorder, as they are effective in alleviating symptoms and improving overall mental health [<a href="#pone.0329559.ref005" class="usa-link" aria-describedby="pone.0329559.ref005">5</a>–<a href="#pone.0329559.ref007" class="usa-link" aria-describedby="pone.0329559.ref007">7</a>]. The prevalence of sexual dysfunction among individuals using antipsychotic medication is estimated to range 16–60%, depending on the specific agent, assessment method, and population studied [<a href="#pone.0329559.ref008" class="usa-link" aria-describedby="pone.0329559.ref008">8</a>,<a href="#pone.0329559.ref009" class="usa-link" aria-describedby="pone.0329559.ref009">9</a>].</p>
<p>Sexual dysfunctions resulting from antipsychotic medications are recognized as most distressing side effects [<a href="#pone.0329559.ref010" class="usa-link" aria-describedby="pone.0329559.ref010">10</a>]. Sexual dysfunctions can lead to lower self-esteem, reduced quality of life, and reduced adherence to therapy [<a href="#pone.0329559.ref011" class="usa-link" aria-describedby="pone.0329559.ref011">11</a>,<a href="#pone.0329559.ref012" class="usa-link" aria-describedby="pone.0329559.ref012">12</a>]. Many patients with schizophrenia discontinue their antipsychotic treatment due to sexual dysfunction (42% of men and 15% of women) [<a href="#pone.0329559.ref013" class="usa-link" aria-describedby="pone.0329559.ref013">13</a>]. This discontinuation is linked to higher rates of relapse, rehospitalization, suicide mortality, cardiovascular mortality, and all-cause mortality [<a href="#pone.0329559.ref014" class="usa-link" aria-describedby="pone.0329559.ref014">14</a>].</p>
<p>Antipsychotics thought to affect the sexual response cycle directly through antagonistic effects on the dopamine system (e.g., desire, arousal, and orgasm) and indirectly contribute to sexual dysfunction (e.g., through weight gain, anticholinergic effects and elevated prolactin levels) [<a href="#pone.0329559.ref015" class="usa-link" aria-describedby="pone.0329559.ref015">15</a>,<a href="#pone.0329559.ref016" class="usa-link" aria-describedby="pone.0329559.ref016">16</a>]. The sexual side effects of antipsychotic medication can be explained through several neurobiological mechanisms. Although the group of antipsychotics is pharmacologically heterogeneous, they all have an affinity for the dopamine system, either as partial agonists or full dopamine antagonists, which are agents that block dopamine receptors—primarily D2 receptors—to inhibit dopaminergic neurotransmission. The intensity of dopamine blockade and whether an antipsychotic is only blocking dopamine (antagonists) or also have their own dopaminergic activities (partial agonists) cause differential effects on the dopamine system and possibly the associated influence on sexual (dys)function<em>.</em> Dopamine plays a crucial role in various brain functions, including sexual interest, sexual arousal, orgasm, and learning. Manipulating dopaminergic receptors often affects sexual behaviour in mammals, including humans [<a href="#pone.0329559.ref017" class="usa-link" aria-describedby="pone.0329559.ref017">17</a>]. Consequently, many antipsychotics may impact sexual performance through dopaminergic mechanisms [<a href="#pone.0329559.ref018" class="usa-link" aria-describedby="pone.0329559.ref018">18</a>].</p>
<p>Prolactin secretion is regulated by the modulation of pituitary dopamine 2 (D2) receptors, with dopamine inhibiting prolactin secretion. Effects of antipsychotics on the dopamine receptors in the pituitary interferes with physiologic dopaminergic modulation, resulting in increased or decreased prolactin secretion in peripheral blood [<a href="#pone.0329559.ref005" class="usa-link" aria-describedby="pone.0329559.ref005">5</a>]. Hyperprolactinemia (abnormally elevated level of serum prolactin) can lead to hypogonadism, reduced testosterone levels, and disruption of the hypothalamic-pituitary-gonadal axis. Prolactin elevation as well as its secondary disruption of the hypothalamic-pituitary-gonadal axis is thought to contribute to decreased sexual desire, sexual arousal, anorgasmia, amenorrhea, infertility, gynecomastia, and galactorrhoea [<a href="#pone.0329559.ref019" class="usa-link" aria-describedby="pone.0329559.ref019">19</a>]. However, newer antipsychotics with partial agonistic effects on the dopamine system may hardly influence or even decrease prolactin secretion.</p>
<p>Other neurotransmitter receptors that may contribute to effects of antipsychotics on sexual functioning are histaminergic, serotonergic, cholinergic, and alpha-adrenergic receptors. These receptor systems may impact sexual function by inhibiting for example motivation and reward, as well as peripheral bodily functions (e.g., peripheral vasodilation) [<a href="#pone.0329559.ref020" class="usa-link" aria-describedby="pone.0329559.ref020">20</a>].</p>
<p>Newer antipsychotics, including aripiprazole, brexpiprazole, cariprazine, and lurasidone, have been introduced for possible beneficial side effect profiles and potential advancements in the treatment of affective disorders [<a href="#pone.0329559.ref021" class="usa-link" aria-describedby="pone.0329559.ref021">21</a>]. Partial dopamine agonistic effects and/or serotonergic agonistic effects on the 5HT1a receptors may improve initiative, reduce anxiety and improve depressive symptoms. Some studies found that these agents are indeed less likely to cause sexual dysfunction [<a href="#pone.0329559.ref022" class="usa-link" aria-describedby="pone.0329559.ref022">22</a>]. Third generation antipsychotics (aripiprazole, brexpiprazole and cariprazine) are all partial dopaminergic agonists) [<a href="#pone.0329559.ref023" class="usa-link" aria-describedby="pone.0329559.ref023">23</a>]. They have been primarily developed aiming to cause less movement disorders and improve negative symptoms [<a href="#pone.0329559.ref024" class="usa-link" aria-describedby="pone.0329559.ref024">24</a>,<a href="#pone.0329559.ref025" class="usa-link" aria-describedby="pone.0329559.ref025">25</a>]. They are less sedating and having only a limited influence on prolactin levels in comparison to first- and second-generation antipsychotics [<a href="#pone.0329559.ref005" class="usa-link" aria-describedby="pone.0329559.ref005">5</a>]. Some studies suggest that these partial dopamine antagonists are less associated with undesired effects on sexual functioning [<a href="#pone.0329559.ref010" class="usa-link" aria-describedby="pone.0329559.ref010">10</a>]. Lurasidone, acts as an antagonist at D(2) and 5-HT [<a href="#pone.0329559.ref007" class="usa-link" aria-describedby="pone.0329559.ref007">7</a>] receptors and as a partial agonist at the 5-HT(1A) receptor subtype [<a href="#pone.0329559.ref026" class="usa-link" aria-describedby="pone.0329559.ref026">26</a>]. These newer antipsychotics may hold promise in offering dual benefits: efficacy in treating of psychotic and affective symptoms while minimizing the likelihood of causing sexual dysfunction.</p>
<p>In 2011, a meta-analysis on sexual dysfunction in patients with mental health disorders using antipsychotics was performed and showed that different antipsychotics influence various dimensions of sexual function [<a href="#pone.0329559.ref008" class="usa-link" aria-describedby="pone.0329559.ref008">8</a>]. Since then, significant advancements have occurred, including the approval and widespread use of newer antipsychotic agents, alongside a growing body of research investigating their side effect profiles. Given these developments, there is a clear need to update and expand upon the previous synthesis [<a href="#pone.0329559.ref027" class="usa-link" aria-describedby="pone.0329559.ref027">27</a>]. This updated review differs from the 2011 meta-analysis by incorporating recent studies, including newer antipsychotics, and by broadening the scope to include biological correlates such as prolactin. Furthermore, our meta-analysis is based exclusively on controlled studies, enhancing methodological rigor and minimizing bias. By focusing on randomized controlled trials and other controlled designs, this review aims to provide more robust and clinically relevant estimates of antipsychotic-induced sexual dysfunction.</p>
<section id="sec004"><h3 class="pmc_sec_title">Aim</h3>
<p>The aim of this meta-analysis is to systematically review and quantitatively analyse the available literature on sexual functioning associated with antipsychotic use. We will perform network meta-analysis techniques, which integrate both direct evidence from clinical trials and indirect evidence, facilitating comparisons across all antipsychotics and generating rankings based on their effects on overall sexual functioning and specific domains of the sexual response cycle. This approach will present available evidence into an accessible format, empowering patients and healthcare providers to make informed, evidence-based treatment decisions to promote shared decision making. Tailored treatment with antipsychotics may contribute to improve sexual health and overall well-being. Additionally, the systematic review may also identify gaps in research that may inspire future studies.</p></section></section><section id="sec005"><h2 class="pmc_sec_title">Methods and analyses</h2>
<p>We will perform a systematic review and meta-analysis according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA-P) guidelines (see <a href="#pone.0329559.s001" class="usa-link">S1 File</a> PRISMA-P). Prior to start of article inclusion, study methods is registered in an international prospective register of systematic reviews (PROSPERO) protocol, registration number: CRD42024573877.</p>
<section id="sec006"><h3 class="pmc_sec_title">Search strategy</h3>
<p>Various databases, including PubMed, MEDLINE, PsychINFO, Web of Science, Cochrane Central Register of Controlled trials (CENTRAL), Embase and CINAHL will be searched. For published, unpublished and ongoing RCTs, a manual search will be conducted utilizing the following trial registries and websites: the European Medicines Agency (EMA) in the European Union, the Food and Drug Administration (FDA) in the USA, the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, the Medicines Evaluation Board (MEB) in the Netherlands, the Medical Products Agency (MPA) in Sweden, the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, and the Therapeutic Goods Administration (TGA) in Australia. There will be no language restrictions, and the search will encompass articles from their inception up to 1 September 2024 and will be re-run on 1 July 2025. For eligible articles published in languages unfamiliar to the reviewers, machine translation tools (e.g., ChatGPT 4.0 or newer versions) will be employed, complemented by back-translation or secondary human verification of critical methodological sections to ensure accuracy and preserve the integrity of the data. The search will be conducted by a professional librarian.</p></section><section id="sec007"><h3 class="pmc_sec_title">Study design</h3>
<p>Only blinded and open randomized controlled trials will be included. Open-label randomized trials will be included in this meta-analysis to ensure comprehensive coverage of the available evidence, particularly given the limited number of double-blind randomized controlled trials assessing sexual dysfunction in patients treated with antipsychotics. In the case of a crossover study, only the first phase will be considered for data-extraction. All other study designs will be excluded.</p></section><section id="sec008"><h3 class="pmc_sec_title">Inclusion criteria</h3>
<p>Studies will be included if they involve patients diagnosed with a primary mental health disorder, defined as the foremost, clinically significant psychiatric condition currently affecting the individual’s functioning and constituting the main focus of diagnosis or treatment, requiring antipsychotic medication. This includes psychotic disorders (including schizophrenia), depressive disorders, bipolar disorder, obsessive-compulsive disorder, anxiety disorders, and post-traumatic stress disorder (PTSD), diagnosed according to DSM-III(-R), DSM-IV(-TR), DSM-5(-TR), ICD-10, or ICD-11 criteria. Both antipsychotic-naive patients and patients with a history of antipsychotic use will be included, in order to capture a representative clinical population and reflect real-world prescribing practices. Furthermore, the included patients in these studies must be 18 years or older and both female and male patients are included.</p></section><section id="sec009"><h3 class="pmc_sec_title">Exclusion criteria</h3>
<p>Studies will exclude patients diagnosed with concomitant somatic diseases known to cause sexual dysfunction or difficulty (e.g., neurological conditions, diabetes mellitus, thyroid disease, renal disease, hypogonadism, androgen disorders, etc.), as well as patients using multiple antipsychotic agents. Studies involving postpartum patients will also be excluded, as this condition can significantly impact sexual function [<a href="#pone.0329559.ref028" class="usa-link" aria-describedby="pone.0329559.ref028">28</a>]. Substance use is not considered an exclusion criterion, as excluding these patients would significantly limit the generalizability of findings and is often not feasible due to high comorbidity rates in clinical populations treated with antipsychotics [<a href="#pone.0329559.ref029" class="usa-link" aria-describedby="pone.0329559.ref029">29</a>].</p></section><section id="sec010"><h3 class="pmc_sec_title">Types of intervention</h3>
<p>We will include controlled studies on sexual (dys)functions and, if also available, serum prolactin levels in antipsychotics registered in Europe or the USA (i.e., amisulpiride, chlorpromazine, clopenthixol, droperidol, fluphentixol, fluphenazine, haloperidol, loxapine, molindone, perphenazine, pimozide, prochlorperazine, thiothixene, thioridazine, trifluoperazine, aripiprazole, asenapine, brexpiprazole, cariprazine, clozapine, iloperidone, levomepromazine, lurasidone, olanzapine, paliperidone, penfluridol, perazine, quetiapine, risperidone, sulpiride, sertindole, ziprasidone, zuclopenthixol, zotepine). Outcome measures for sexual functioning will include (MeSH) terms such as sexual functioning or performance, sexual desire (disorders), sexual arousal (disorders), and orgasmic (disorders) along with related terms (see supplementary <a href="#pone.0329559.s002" class="usa-link">S1 Appendix</a>) [<a href="#pone.0329559.ref002" class="usa-link" aria-describedby="pone.0329559.ref002">2</a>,<a href="#pone.0329559.ref005" class="usa-link" aria-describedby="pone.0329559.ref005">5</a>].</p></section><section id="sec011"><h3 class="pmc_sec_title">Outcomes</h3>
<p>Studies reporting on the prevalence of sexual dysfunctions in psychiatric patients using antipsychotics and also assessing sexual dysfunction by standardized and validated sexual questionnaires will be included, e.g., PRSexDQ (Psychotropic-Related Sexual Dysfunction Questionnaire), ASEX (Arizona Sexual Experience Scale), UKU (Udvalg for Kliniske Undersøgelser), CSFQ (Changes in Sexual Function Questionnaire), ASFQ, or any other validated and standardized rating scale [<a href="#pone.0329559.ref030" class="usa-link" aria-describedby="pone.0329559.ref030">30</a>]. Studies reporting sexual dysfunction rates based on spontaneous reports or semi-structured interviews lacking validated and standardized assessment tools will be excluded. This approach ensures the use of validated and standardized questionnaires, thereby enhancing the internal validity of the analysis and minimizing heterogeneity across included studies, which is essential for robust quantitative synthesis and comparability. Studies combining two or more outcome measures (e.g., combining desire and arousal disorders) or rating sexual dysfunctions that does not align with standard outcome measures will also be excluded.</p>
<p>If eligible studies are included, they will be screened for the potential quantification of serum prolactin levels. If available, changes of serum prolactin levels will be measured from baseline to week 8 (or as close to 8 weeks as possible). We will use the internationally standardized normal values of serum prolactin [<a href="#pone.0329559.ref031" class="usa-link" aria-describedby="pone.0329559.ref031">31</a>].</p></section><section id="sec012"><h3 class="pmc_sec_title">Primary outcome</h3>
<p>The rate of sexual dysfunctions in patients after 8 weeks (or as close to 8 weeks as possible) of medication use, will be assessed as overall sexual dysfunction (either as continuous or dichotomous outcome). This outcome will be assessed by using the reported scores from validated sexual function rating scales [<a href="#pone.0329559.ref032" class="usa-link" aria-describedby="pone.0329559.ref032">32</a>]. We will report the number and percentage of patients reporting sexual dysfunction per study arm at 8 weeks (or as close as possible). If scores at 8 weeks are not reported but change scores are available, we will utilize the latter scores.</p></section><section id="sec013"><h3 class="pmc_sec_title">Secondary outcomes</h3>
<ol class="list" style="list-style-type:decimal">
<li><p>The rate of three aspects of sexual dysfunction will be studied: desire, arousal (erection and lubrication), orgasm (including delayed and premature ejaculation in men) [<a href="#pone.0329559.ref033" class="usa-link" aria-describedby="pone.0329559.ref033">33</a>]</p></li>
<li><p>The rate of changes in serum prolactin levels</p></li>
</ol></section><section id="sec014"><h3 class="pmc_sec_title">Identification and selection of studies</h3>
<p>Two independent reviewers will screen and select articles through a systematic process. Titles, abstracts and full-text screening will be evaluated independently by both reviewers. In cases of uncertainty or disagreement, a third reviewer will be consulted to make a final decision regarding inclusion. The selected studies will be screened for potential cross-references. Registration studies for the included antipsychotics will be reviewed to identify any unpublished data on sexual function. In case of multiple articles based on the same dataset, only the primary article will be included. A detailed record of the reasons for excluding articles will be created (see <a href="#pone.0329559.g001" class="usa-link">Fig 1</a>). An online systematic review program (Covidence) will be used to facilitate a structured identification and selection process.</p>
<figure class="fig xbox font-sm" id="pone.0329559.g001"><h4 class="obj_head">Fig 1. Decision-tree for selecting articles and extracting data.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7c/12370141/62d48b906890/pone.0329559.g001.jpg" loading="lazy" height="1134" width="800" alt="Fig 1"></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329559.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec015"><h3 class="pmc_sec_title">Study timeline</h3>
<p>This study follows a structured approach, progressing through key stages of data collection and analysis. As of 11 February 2025, we are in the early phases of the study, specifically focused on record screening. The timeline for the remaining phases is estimated as follows:</p>
<p>Record Screening: currently ongoing, with an expected completion by 1 June 2025.</p>
<p>Data Extraction: scheduled to begin following the completion of record screening, estimated to be completed by 1 August 2025.</p>
<p>Results Analysis and Reporting: Once data extraction is finalized, analysis will commence, with preliminary results expected by 1 September 2025.</p></section><section id="sec016"><h3 class="pmc_sec_title">Data extraction process</h3>
<p>Two independent reviewers will extract data from the selected articles. To ensure accuracy, they will cross-verify the input of data into the final dataset. In addition, study authors will be contacted for clarification on unclear data or to provide any missing information.</p>
<p>By using a standardized data extraction form, all relevant data per study will be collected, including:</p>
<ul class="list" style="list-style-type:disc">
<li><p>Study characteristics: Information such as the first author, year of publication, journal, sample size, country where the study was conducted, study design (e.g., non-blinded), name of the questionnaire used to assess sexual functioning, trial duration (follow-up), and sponsorship.</p></li>
<li><p>Participant demographics: Data on participant sex (% female), mean age, diagnosis, baseline prolactin levels, baseline sexual dysfunction, and use of concomitant antidepressants.</p></li>
<li><p>Details of antipsychotic medication: Information on the antipsychotic treatments studied in each study arm, including the name of the medication (or placebo), dosage (flexible or fixed), dosage comparability (yes/no), and duration of use.</p></li>
<li><p>Outcomes per study arm: Key outcomes such as the number of participants randomized, number (%) of patients reporting sexual dysfunction, mean scores with standard deviations on sexual function questionnaires, number of missing data points, number lost to follow-up, number of imputed data points, imputation techniques used, and serum prolactin levels.</p></li>
</ul>
<p>Data will be extracted from an 8-week follow-up, as this period aligns with most trial designs for evaluating sexual function after starting antipsychotics. If 8-week data are unavailable, outcomes closest to the 8-week mark will be used. Both fixed-dose and flexible-dose designs will be included. When comparing drugs at different dosage levels within their therapeutic ranges (e.g., upper versus lower limits), a dichotomous variable is used to indicate dosage comparability [<a href="#pone.0329559.ref034" class="usa-link" aria-describedby="pone.0329559.ref034">34</a>].</p></section><section id="sec017"><h3 class="pmc_sec_title">Measurement of (adverse) effects on sexual function</h3>
<p>We will use the number and percentage of patients reporting sexual dysfunction per study arm at 8 weeks (or the closest available time point). If scores at 8 weeks are unreported but change scores are provided, these will be used instead.</p>
<p>When the number of patients experiencing sexual dysfunction is not directly reported but means (with SD or SE) for baseline and endpoint data on a sexual dysfunction rating scale are available, Furukawa et al.’s method will be applied to estimate the number of affected patients [<a href="#pone.0329559.ref032" class="usa-link" aria-describedby="pone.0329559.ref032">32</a>]. Furukawa et al found that assuming normal distributions, while often such symptom measures are skewed and not normally distributed, did not affect the conclusions drawn. We will perform sensitivity analyses to assess the impact of including studies in the analyses in which data was imputed.</p>
<p>When response rates are imputed from means and SDs, a decrease of 50% or more in baseline scores will indicate sexual dysfunction in the absence of established norms. The SD will be used to estimate variability, with SEs converted into SDs. If neither SDs nor SEs are available, they will be calculated using confidence intervals, <em>t</em>-values, or <em>p</em>-values, following the methods outlined in the Cochrane Handbook for Systematic Reviews [<a href="#pone.0329559.ref035" class="usa-link" aria-describedby="pone.0329559.ref035">35</a>,<a href="#pone.0329559.ref036" class="usa-link" aria-describedby="pone.0329559.ref036">36</a>]. If studies present the results with and without imputation of missing data, imputed data will be prioritized, and completer-only analyses will be disregarded.</p>
<p>Mixed models will be preferred over the Last Observation Carried Forward (LOCF) method, as they provide a more accurate and reliable approach to handling missing data by incorporating all available information and accounting for variability over time [<a href="#pone.0329559.ref037" class="usa-link" aria-describedby="pone.0329559.ref037">37</a>]. If data are presented in graphical form only, values will be extracted from the figures. When other methods are unfeasible, the original study authors will be contacted for clarification or additional information.</p></section><section id="sec018"><h3 class="pmc_sec_title">Risk of bias assessment</h3>
<p>The Cochrane Risk of Bias (RoB 2.0) tool for randomized controlled trials will be used to assess the quality of included studies [<a href="#pone.0329559.ref038" class="usa-link" aria-describedby="pone.0329559.ref038">38</a>]. This evaluation will be conducted independently by two reviewers. Any discrepancies between reviewers will be resolved through consensus, with the involvement of an additional member of the review team for resolution if necessary. When insufficient information is provided, we may contact the authors to request additional details.</p>
<p>We will address the potential biases in the following areas: the generating of the allocation sequence, concealing the allocation, blinding of both study personnel and participants, blinding of outcome reviewers, management of attrition, selective reporting of outcomes, imputation techniques used, and other relevant factors, including potential sponsorship bias. When insufficient information about allocation concealment and other trial characteristics is supplied, it may be necessary to reach out to the authors of the trial for additional details.</p>
<p>The quality assessment for bias risk will be categorized in three categories: low risk of bias (none of the evaluated aspects were considered as high risk, and three or less were considered as unclear risk), moderate risk of bias (one of the above evaluated aspects was considered as high risk, or none were considered as high risk, but four or more were rated as unclear risk) and high risk of bias (all other scores that do not fit the criteria for low or moderate risk of bias).</p></section><section id="sec019"><h3 class="pmc_sec_title">Statistical analysis</h3>
<section id="sec020"><h4 class="pmc_sec_title">Descriptive statistics.</h4>
<p>We will compile descriptive statistics to summarize the trial and study population characteristics from all eligible trials. This process will involve outlining the various types of comparisons and outline of key clinical and methodological variables, including year of publication, type of psychiatric disorder, proportion of participants allocated to placebo, age, sponsorship, and clinical setting. This comprehensive overview will offer valuable insights into the diversity and scope of the included studies.</p></section><section id="sec021"><h4 class="pmc_sec_title">Pair-wise meta-analysis.</h4>
<p>Initially, we will conduct a traditional pairwise meta-analyses by pooling studies that evaluate identical interventions (antipsychotics), including comparisons between active treatments and various control groups. We will use a random-effects frequentist model for these pairwise meta-analyses.</p>
<p>We will quantify heterogeneity using tau-squared, which represents the between-study variance. We will assume a common heterogeneity variance across treatment comparisons and classify the level of heterogeneity as low, moderate, or high using empirical distributions based on the first and third quantiles [<a href="#pone.0329559.ref039" class="usa-link" aria-describedby="pone.0329559.ref039">39</a>,<a href="#pone.0329559.ref040" class="usa-link" aria-describedby="pone.0329559.ref040">40</a>]. Additionally, we will explore whether treatment effects for the two primary outcomes are robust in subgroup analyses and network meta-regression using the following study and participant characteristics: [<a href="#pone.0329559.ref001" class="usa-link" aria-describedby="pone.0329559.ref001">1</a>] publication year, [<a href="#pone.0329559.ref002" class="usa-link" aria-describedby="pone.0329559.ref002">2</a>] psychiatric diagnosis, [<a href="#pone.0329559.ref003" class="usa-link" aria-describedby="pone.0329559.ref003">3</a>] industry sponsorship, [<a href="#pone.0329559.ref004" class="usa-link" aria-describedby="pone.0329559.ref004">4</a>] treatment duration, and [<a href="#pone.0329559.ref005" class="usa-link" aria-describedby="pone.0329559.ref005">5</a>] gender distribution. The sensitivity of our findings will be further evaluated by conducting analyses restricted to: [<a href="#pone.0329559.ref001" class="usa-link" aria-describedby="pone.0329559.ref001">1</a>] studies with complete outcome data (i.e., no imputation performed by the primary authors), [<a href="#pone.0329559.ref002" class="usa-link" aria-describedby="pone.0329559.ref002">2</a>] studies in which we did not impute response data based on means and SD’s, [<a href="#pone.0329559.ref003" class="usa-link" aria-describedby="pone.0329559.ref003">3</a>] studies with comparable antipsychotic dosages across arms, [<a href="#pone.0329559.ref004" class="usa-link" aria-describedby="pone.0329559.ref004">4</a>] studies providing unpublished data, [<a href="#pone.0329559.ref005" class="usa-link" aria-describedby="pone.0329559.ref005">5</a>] studies assessed as having a low risk of bias according to the predefined risk of bias criteria, [<a href="#pone.0329559.ref006" class="usa-link" aria-describedby="pone.0329559.ref006">6</a>] blinded trials, and [<a href="#pone.0329559.ref007" class="usa-link" aria-describedby="pone.0329559.ref007">7</a>] direct head-to-head trials only.</p>
<p>To address potential multicollinearity among covariates in the network meta-regression analyses, we will examine variance inflation factors (VIFs). Variables exhibiting high collinearity (i.e., VIF values exceeding acceptable thresholds) will be either excluded from the model or combined with related variables, as appropriate, to preserve model stability and interpretability.</p></section><section id="sec022"><h4 class="pmc_sec_title">Network meta-analysis.</h4>
<p>The fundamental assumption of network meta-analysis (NMA), known as transitivity, will undergo thorough analysis. A comprehensive evaluation of treatments will assess whether the included studies are comparable, as significant intransitivity can result in misleading conclusions. To validate indirect evidence, clinical and methodological variables serving as potential effect modifiers (e.g., sex, age, dosage) will be examined across various treatment comparisons [<a href="#pone.0329559.ref041" class="usa-link" aria-describedby="pone.0329559.ref041">41</a>]. This analysis will determine whether these variables are equally distributed among studies within each comparison category. We will focus on: sex, mean age, diagnosis, baseline prolactin levels, baseline sexual dysfunction, use of concomitant antidepressants, dosage of anti-psychotic medication, type of dosage (flexible or fixed), and duration of use.</p>
<p>If the gathered studies demonstrate sufficient transitivity, a random-effects network meta-analysis (NMA) will be conducted to synthesize both direct and indirect evidence for outcomes related to sexual dysfunction and prolactin levels. The results will generate ranking of all treatments, presented as summary risk ratios (RRs) or standardized mean differences (SMD) in a league table, complete with confidence intervals. We will visually represent the available direct evidence using a network diagram. The size of each node in the diagram will reflect the volume of evidence for each treatment, based on the total number of patients involved. The connecting lines will be weighted according to the inverse of the variance of the summary effect from each comparison. If the conditions for network meta-analysis are not fulfilled, only the results of the pairwise syntheses will be reported.</p>
<p>We expect substantial heterogeneity between studies, which may lead to inconsistency. We will apply the separate indirect from direct evidence (SIDE) method, to assess the agreement between indirect and direct evidence for every possible comparison in the network [<a href="#pone.0329559.ref042" class="usa-link" aria-describedby="pone.0329559.ref042">42</a>]. In case we observe local inconsistency, we will examine possible sources like data-entry mistakes or differences in study characteristics.</p>
<p>To ensure the robustness of different medical treatments on our outcomes, we will conduct subgroup analyses based on the following characteristics: [<a href="#pone.0329559.ref001" class="usa-link" aria-describedby="pone.0329559.ref001">1</a>] baseline levels of sexual function, [<a href="#pone.0329559.ref002" class="usa-link" aria-describedby="pone.0329559.ref002">2</a>] blinding, [<a href="#pone.0329559.ref003" class="usa-link" aria-describedby="pone.0329559.ref003">3</a>] type of psychiatric disorder, [<a href="#pone.0329559.ref004" class="usa-link" aria-describedby="pone.0329559.ref004">4</a>] concomitant with antidepressants, [<a href="#pone.0329559.ref005" class="usa-link" aria-describedby="pone.0329559.ref005">5</a>] gender and [<a href="#pone.0329559.ref006" class="usa-link" aria-describedby="pone.0329559.ref006">6</a>] age. In addition, we will assess the validity of our conclusions by re-analysing the following conditions:</p>
<ul class="list" style="list-style-type:disc">
<li><p>Including only studies with reported standard deviations (SD) rather than imputed values.</p></li>
<li><p>Including only studies with balanced doses in all arms (excluding studies with unequal dose comparisons).</p></li>
<li><p>Including only studies with a low risk of bias.</p></li>
</ul>
<p>As the potential for selection bias is elevated in trials involving antipsychotics, we will evaluate whether there are differences in outcomes between less precise trials and more precise trials [<a href="#pone.0329559.ref043" class="usa-link" aria-describedby="pone.0329559.ref043">43</a>]. Comparison-adjusted and contour-enhanced funnel plots are generated when more than 10 studies are included. To further explore associations, network meta-regression models will be used to examine the relationship between study size and effect size. If a significant association is identified, publication bias is suspected, we will investigate funnel plot asymmetry using a selection model to account for potential publication bias.</p>
<p>The R-package ‘netmeta’ will be employed for all these analyses. In addition, within R, we will use the netsplit (SIDE method) and the RoB 2.0 tool to evaluate the risk of bias due to missing evidence in the NMA [<a href="#pone.0329559.ref044" class="usa-link" aria-describedby="pone.0329559.ref044">44</a>]. We will consider <em>p</em>-values &lt; .05 as statistically significant.</p></section></section><section id="sec023"><h3 class="pmc_sec_title">GRADE</h3>
<p>The review will conclude with a comprehensive summary of findings and an evaluation of the confidence in the evidence. Using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework, we will evaluate the overall certainty of evidence for each outcome. Results will be categorized and presented in outcome tables, in accordance with The Cochrane Collaboration’s recommendations [<a href="#pone.0329559.ref045" class="usa-link" aria-describedby="pone.0329559.ref045">45</a>].</p></section><section id="sec024"><h3 class="pmc_sec_title">Ethics and dissemination</h3>
<p>Ethical approval is not required for this systematic review and meta-analysis as we perform a secondary analysis of publicly available data. Upon completion, the review will be submitted for publication in a peer-reviewed journal. The dataset and other supplementary materials will be made available. Also, the results of this review will be disseminated through print, social media, and presentations at relevant conferences.</p></section></section><section id="sec025"><h2 class="pmc_sec_title">Discussion</h2>
<p>By systematically comparing the sexual side effects and prolactin-related impacts of various antipsychotics, this study aims to provide clinicians with evidence-based guidance for selecting medications that minimize sexual dysfunction, a key factor affecting patient adherence. Improved understanding of these side effect profiles can enhance shared decision-making, support personalized treatment plans, and ultimately improve treatment adherence and quality of life [<a href="#pone.0329559.ref002" class="usa-link" aria-describedby="pone.0329559.ref002">2</a>]. Furthermore, the findings may inform the development of targeted interventions and monitoring strategies to mitigate sexual dysfunction, thereby optimizing long-term psychiatric care.</p>
<p>The protocol’s rigorous methodology ensures reliable and valid findings, with strengths in its broad scope, advanced analytical approach, and high practical relevance. The review evaluates a wide range of antipsychotics, including newer-generation options, and employs validated sexual function questionnaires to ensure standardized outcome measures. Incorporating prolactin levels as a secondary outcome, the study provides insight into potential mechanisms linking antipsychotic induced alterations of prolactin levels to sexual dysfunction. Network meta-analysis facilitates treatment comparison and ranking, supporting evidence-based clinical decision making. Furthermore, exploration of heterogeneity through subgroup analyses, meta-regression, and robustness checks enhances depth and credibility of the findings. Clinically, the findings will guide shared decision-making, identifying less harmful options, ultimately improve adherence, reduce relapse, and enhance patient outcomes.</p>
<p>Potential challenges include heterogeneity in study designs, populations, and dosages, which may introduce confounding despite the use of subgroup analyses and meta-regression. Bias in included trials, such as inadequate blinding or pharmaceutical sponsorship, will be mitigated using the Cochrane Risk of Bias 2.0 tool, though complete elimination of bias is unlikely. The use of subjective self-reported questionnaires, although validated, may introduce recall bias. Consequently, some nuances related to patient-reported experiences and context-specific factors might not be fully captured, which could limit the comprehensiveness of the findings. Another limitation of this review is the exclusion of studies that rely on spontaneous reports or semi-structured interviews without the use of validated and standardized instruments for assessing the prevalence of sexual dysfunction. While this decision enhances the internal validity and comparability of included studies by reducing heterogeneity, it may also result in the omission of potentially valuable qualitative data and clinically relevant insights. Publication bias, where studies remain unpublished, will be addressed using funnel plots and selection models. Additionally, differences in participant characteristics across studies may challenge the assumption of transitivity in network meta-analysis, requiring cautious interpretation of results.</p>
<p>By proactively addressing these limitations, the study aims to provide clinically relevant findings to improve the management of sexual side effects in patients treated with antipsychotics, ultimately enhancing patient care and quality of life.</p></section><section id="sec026"><h2 class="pmc_sec_title">Conclusion</h2>
<p>The findings of this meta-analysis can directly inform clinical practice guidelines by providing robust, comparative evidence on the sexual side effect profiles of various antipsychotic medications. Incorporating these results into treatment recommendations will enable clinicians to better balance efficacy and tolerability when selecting antipsychotics, particularly for patients at risk of or experiencing sexual dysfunction. This evidence-based approach supports personalized medicine by guiding prescribers toward options with lower sexual adverse effects, potentially enhancing patient adherence and satisfaction. Furthermore, the integration of these findings into clinical guidelines can promote shared decision-making between clinicians and patients, fostering informed discussions about treatment choices and potential side effects. Ultimately, this will contribute to improved long-term outcomes by reducing treatment discontinuation related to sexual dysfunction and enhancing overall quality of life.</p></section><section id="sec027"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0329559.s001"><div class="caption p">
<span>S1 File. PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s001.pdf</a><sup> (101KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329559.s002"><div class="caption p">
<span>S1 Appendix. Search terms for study screening.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s002.pdf</a><sup> (661.8KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors thank Margot Verleg (MV) for her expertise and assistance in conducting the search for articles.</p></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) received no specific funding for this work.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0329559.ref001">
<span class="label">1.</span><cite>Basson R, Gilks T. Women’s sexual dysfunction associated with psychiatric disorders and their treatment. Womens Health (Lond). 2018;14:1745506518762664. doi: 10.1177/1745506518762664

</cite> [<a href="https://doi.org/10.1177/1745506518762664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5900810/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29649948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Womens%20Health%20(Lond)&amp;title=Women%E2%80%99s%20sexual%20dysfunction%20associated%20with%20psychiatric%20disorders%20and%20their%20treatment&amp;author=R%20Basson&amp;author=T%20Gilks&amp;volume=14&amp;publication_year=2018&amp;pages=1745506518762664&amp;pmid=29649948&amp;doi=10.1177/1745506518762664&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref002">
<span class="label">2.</span><cite>Herder T, Spoelstra SK, Peters AWM, Knegtering H. Sexual dysfunction related to psychiatric disorders: a systematic review. J Sex Med. 2023;20(7):965–76. doi: 10.1093/jsxmed/qdad074

</cite> [<a href="https://doi.org/10.1093/jsxmed/qdad074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37279603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Sex%20Med&amp;title=Sexual%20dysfunction%20related%20to%20psychiatric%20disorders:%20a%20systematic%20review&amp;author=T%20Herder&amp;author=SK%20Spoelstra&amp;author=AWM%20Peters&amp;author=H%20Knegtering&amp;volume=20&amp;issue=7&amp;publication_year=2023&amp;pages=965-76&amp;pmid=37279603&amp;doi=10.1093/jsxmed/qdad074&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref003">
<span class="label">3.</span><cite>Association AP. Diagnostic and Statistical Manual of Mental Disorders. 5 edition. Washington, DC: American Psychiatric Publishing; 2013.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Diagnostic%20and%20Statistical%20Manual%20of%20Mental%20Disorders&amp;author=AP%20Association&amp;publication_year=2013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref004">
<span class="label">4.</span><cite>Montejo AL, Montejo L, Navarro-Cremades F. Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psych. 2015;28(6):418–23. doi: 10.1097/YCO.0000000000000198

</cite> [<a href="https://doi.org/10.1097/YCO.0000000000000198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26382168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Psych&amp;title=Sexual%20side-effects%20of%20antidepressant%20and%20antipsychotic%20drugs&amp;author=AL%20Montejo&amp;author=L%20Montejo&amp;author=F%20Navarro-Cremades&amp;volume=28&amp;issue=6&amp;publication_year=2015&amp;pages=418-23&amp;pmid=26382168&amp;doi=10.1097/YCO.0000000000000198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref005">
<span class="label">5.</span><cite>Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939–51.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(19)31135-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6891890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31303314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Comparative%20efficacy%20and%20tolerability%20of%2032%20oral%20antipsychotics%20for%20the%20acute%20treatment%20of%20adults%20with%20multi-episode%20schizophrenia:%20a%20systematic%20review%20and%20network%20meta-analysis&amp;author=M%20Huhn&amp;author=A%20Nikolakopoulou&amp;author=J%20Schneider-Thoma&amp;author=M%20Krause&amp;author=M%20Samara&amp;volume=394&amp;issue=10202&amp;publication_year=2019&amp;pages=939-51&amp;pmid=31303314&amp;doi=10.1016/S0140-6736(19)31135-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref006">
<span class="label">6.</span><cite>Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Mishima K, et al. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials. Mol Psych. 2021;26(8):4146–57. doi: 10.1038/s41380-020-00946-6

</cite> [<a href="https://doi.org/10.1038/s41380-020-00946-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8550938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33177610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Psych&amp;title=Mood%20stabilizers%20and/or%20antipsychotics%20for%20bipolar%20disorder%20in%20the%20maintenance%20phase:%20a%20systematic%20review%20and%20network%20meta-analysis%20of%20randomized%20controlled%20trials&amp;author=T%20Kishi&amp;author=T%20Ikuta&amp;author=Y%20Matsuda&amp;author=K%20Sakuma&amp;author=M%20Okuya&amp;volume=26&amp;issue=8&amp;publication_year=2021&amp;pages=4146-57&amp;pmid=33177610&amp;doi=10.1038/s41380-020-00946-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref007">
<span class="label">7.</span><cite>Jha MK, Mathew SJ. Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape. Am J Psych. 2023;180(3):190–9. doi: 10.1176/appi.ajp.20230025

</cite> [<a href="https://doi.org/10.1176/appi.ajp.20230025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36855876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Psych&amp;title=Pharmacotherapies%20for%20Treatment-Resistant%20Depression:%20How%20Antipsychotics%20Fit%20in%20the%20Rapidly%20Evolving%20Therapeutic%20Landscape&amp;author=MK%20Jha&amp;author=SJ%20Mathew&amp;volume=180&amp;issue=3&amp;publication_year=2023&amp;pages=190-9&amp;pmid=36855876&amp;doi=10.1176/appi.ajp.20230025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref008">
<span class="label">8.</span><cite>Serretti A, Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol. 2011;26(3):130–40. doi: 10.1097/YIC.0b013e328341e434

</cite> [<a href="https://doi.org/10.1097/YIC.0b013e328341e434" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21191308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Clin%20Psychopharmacol&amp;title=A%20meta-analysis%20of%20sexual%20dysfunction%20in%20psychiatric%20patients%20taking%20antipsychotics&amp;author=A%20Serretti&amp;author=A%20Chiesa&amp;volume=26&amp;issue=3&amp;publication_year=2011&amp;pages=130-40&amp;pmid=21191308&amp;doi=10.1097/YIC.0b013e328341e434&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref009">
<span class="label">9.</span><cite>Montejo AL, Montejo L, Navarro-Cremades F. Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psych. 2015;28(6):418–23. doi: 10.1097/YCO.0000000000000198

</cite> [<a href="https://doi.org/10.1097/YCO.0000000000000198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26382168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Psych&amp;title=Sexual%20side-effects%20of%20antidepressant%20and%20antipsychotic%20drugs&amp;author=AL%20Montejo&amp;author=L%20Montejo&amp;author=F%20Navarro-Cremades&amp;volume=28&amp;issue=6&amp;publication_year=2015&amp;pages=418-23&amp;pmid=26382168&amp;doi=10.1097/YCO.0000000000000198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref010">
<span class="label">10.</span><cite>Montejo AL, de Alarcón R, Prieto N, Acosta JM, Buch B, Montejo L. Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach. J Clin Med. 2021;10(2):308. doi: 10.3390/jcm10020308

</cite> [<a href="https://doi.org/10.3390/jcm10020308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7829881/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33467621/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Med&amp;title=Management%20Strategies%20for%20Antipsychotic-Related%20Sexual%20Dysfunction:%20A%20Clinical%20Approach&amp;author=AL%20Montejo&amp;author=R%20de%20Alarc%C3%B3n&amp;author=N%20Prieto&amp;author=JM%20Acosta&amp;author=B%20Buch&amp;volume=10&amp;issue=2&amp;publication_year=2021&amp;pages=308&amp;pmid=33467621&amp;doi=10.3390/jcm10020308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref011">
<span class="label">11.</span><cite>Hashimoto Y, Uno J, Miwa T, Kurihara M, Tanifuji H, Tensho M. Effects of antipsychotic polypharmacy on side-effects and concurrent use of medications in schizophrenic outpatients. Psych Clin Neurosci. 2012;66(5):405–10. doi: 10.1111/j.1440-1819.2012.02376.x

</cite> [<a href="https://doi.org/10.1111/j.1440-1819.2012.02376.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22834658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psych%20Clin%20Neurosci&amp;title=Effects%20of%20antipsychotic%20polypharmacy%20on%20side-effects%20and%20concurrent%20use%20of%20medications%20in%20schizophrenic%20outpatients&amp;author=Y%20Hashimoto&amp;author=J%20Uno&amp;author=T%20Miwa&amp;author=M%20Kurihara&amp;author=H%20Tanifuji&amp;volume=66&amp;issue=5&amp;publication_year=2012&amp;pages=405-10&amp;pmid=22834658&amp;doi=10.1111/j.1440-1819.2012.02376.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref012">
<span class="label">12.</span><cite>Schmidt HM, Hagen M, Kriston L, Soares-Weiser K, Maayan N, Berner MM. Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev. 2012;11(11):CD003546. doi: 10.1002/14651858.CD003546.pub3

</cite> [<a href="https://doi.org/10.1002/14651858.CD003546.pub3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7003677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23152218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20Syst%20Rev&amp;title=Management%20of%20sexual%20dysfunction%20due%20to%20antipsychotic%20drug%20therapy&amp;author=HM%20Schmidt&amp;author=M%20Hagen&amp;author=L%20Kriston&amp;author=K%20Soares-Weiser&amp;author=N%20Maayan&amp;volume=11&amp;issue=11&amp;publication_year=2012&amp;pmid=23152218&amp;doi=10.1002/14651858.CD003546.pub3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref013">
<span class="label">13.</span><cite>Rosenberg KP, Bleiberg KL, Koscis J, Gross C. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther. 2003;29(4):289–96. doi: 10.1080/00926230390195524

</cite> [<a href="https://doi.org/10.1080/00926230390195524" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14504017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Sex%20Marital%20Ther&amp;title=A%20survey%20of%20sexual%20side%20effects%20among%20severely%20mentally%20ill%20patients%20taking%20psychotropic%20medications:%20impact%20on%20compliance&amp;author=KP%20Rosenberg&amp;author=KL%20Bleiberg&amp;author=J%20Koscis&amp;author=C%20Gross&amp;volume=29&amp;issue=4&amp;publication_year=2003&amp;pages=289-96&amp;pmid=14504017&amp;doi=10.1080/00926230390195524&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref014">
<span class="label">14.</span><cite>Andrade C. Antipsychotic medication continuation vs taper and discontinuation in patients with schizophrenia and other nonaffective psychotic disorders. J Clin Psych. 2024;85(2).</cite> [<a href="https://doi.org/10.4088/JCP.24f15363" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38767930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Psych&amp;title=Antipsychotic%20medication%20continuation%20vs%20taper%20and%20discontinuation%20in%20patients%20with%20schizophrenia%20and%20other%20nonaffective%20psychotic%20disorders&amp;author=C%20Andrade&amp;volume=85&amp;issue=2&amp;publication_year=2024&amp;pmid=38767930&amp;doi=10.4088/JCP.24f15363&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref015">
<span class="label">15.</span><cite>Malik P, Kemmler G, Fleischhacker W. Sexual dysfunction in first-episode schizophrenia patients: results from EUFEST. Int J Neuropsychopharmacol. 2010;13:228-.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Neuropsychopharmacol&amp;title=Sexual%20dysfunction%20in%20first-episode%20schizophrenia%20patients:%20results%20from%20EUFEST&amp;author=P%20Malik&amp;author=G%20Kemmler&amp;author=W%20Fleischhacker&amp;volume=13&amp;publication_year=2010&amp;pages=228&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref016">
<span class="label">16.</span><cite>de Boer MK, Castelein S, Wiersma D, Schoevers RA, Knegtering H. The facts about sexual (dys)function in schizophrenia: an overview of clinically relevant findings. Schizophr Bullet. 2015;41(3):674–86.</cite> [<a href="https://doi.org/10.1093/schbul/sbv001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4393701/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25721311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Schizophr%20Bullet&amp;title=The%20facts%20about%20sexual%20(dys)function%20in%20schizophrenia:%20an%20overview%20of%20clinically%20relevant%20findings&amp;author=MK%20de%20Boer&amp;author=S%20Castelein&amp;author=D%20Wiersma&amp;author=RA%20Schoevers&amp;author=H%20Knegtering&amp;volume=41&amp;issue=3&amp;publication_year=2015&amp;pages=674-86&amp;pmid=25721311&amp;doi=10.1093/schbul/sbv001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref017">
<span class="label">17.</span><cite>Salamone JD, Correa M. The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine. Annu Rev Psychol. 2024;75:1–32. doi: 10.1146/annurev-psych-020223-012208

</cite> [<a href="https://doi.org/10.1146/annurev-psych-020223-012208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37788571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Psychol&amp;title=The%20Neurobiology%20of%20Activational%20Aspects%20of%20Motivation:%20Exertion%20of%20Effort,%20Effort-Based%20Decision%20Making,%20and%20the%20Role%20of%20Dopamine&amp;author=JD%20Salamone&amp;author=M%20Correa&amp;volume=75&amp;publication_year=2024&amp;pages=1-32&amp;pmid=37788571&amp;doi=10.1146/annurev-psych-020223-012208&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref018">
<span class="label">18.</span><cite>Düring SW, Nielsen MØ, Bak N, Glenthøj BY, Ebdrup BH. Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2/3 receptor blockade - An exploratory study. Psychiatry Res. 2019;274:58–65. doi: 10.1016/j.psychres.2019.02.017

</cite> [<a href="https://doi.org/10.1016/j.psychres.2019.02.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30780063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychiatry%20Res&amp;title=Sexual%20dysfunction%20and%20hyperprolactinemia%20in%20schizophrenia%20before%20and%20after%20six%20weeks%20of%20D2/3%20receptor%20blockade%20-%20An%20exploratory%20study&amp;author=SW%20D%C3%BCring&amp;author=M%C3%98%20Nielsen&amp;author=N%20Bak&amp;author=BY%20Glenth%C3%B8j&amp;author=BH%20Ebdrup&amp;volume=274&amp;publication_year=2019&amp;pages=58-65&amp;pmid=30780063&amp;doi=10.1016/j.psychres.2019.02.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref019">
<span class="label">19.</span><cite>Galdiero M, Pivonello R, Grasso LFS, Cozzolino A, Colao A. Growth hormone, prolactin, and sexuality. J Endocrinol Invest. 2012;35(8):782–94. doi: 10.1007/BF03345805

</cite> [<a href="https://doi.org/10.1007/BF03345805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28726215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Endocrinol%20Invest&amp;title=Growth%20hormone,%20prolactin,%20and%20sexuality&amp;author=M%20Galdiero&amp;author=R%20Pivonello&amp;author=LFS%20Grasso&amp;author=A%20Cozzolino&amp;author=A%20Colao&amp;volume=35&amp;issue=8&amp;publication_year=2012&amp;pages=782-94&amp;pmid=28726215&amp;doi=10.1007/BF03345805&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref020">
<span class="label">20.</span><cite>Calabrò RS, Cacciola A, Bruschetta D, Milardi D, Quattrini F, Sciarrone F, et al. Neuroanatomy and function of human sexual behavior: A neglected or unknown issue?
Brain Behav. 2019;9(12):e01389.</cite> [<a href="https://doi.org/10.1002/brb3.1389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6908863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31568703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Behav&amp;title=Neuroanatomy%20and%20function%20of%20human%20sexual%20behavior:%20A%20neglected%20or%20unknown%20issue?&amp;author=RS%20Calabr%C3%B2&amp;author=A%20Cacciola&amp;author=D%20Bruschetta&amp;author=D%20Milardi&amp;author=F%20Quattrini&amp;volume=9&amp;issue=12&amp;publication_year=2019&amp;pmid=31568703&amp;doi=10.1002/brb3.1389&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref021">
<span class="label">21.</span><cite>Corponi F, Fabbri C, Bitter I, Montgomery S, Vieta E, Kasper S, et al. Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone. Eur Neuropsychopharmacol. 2019;29(9):971–85.
</cite> [<a href="https://doi.org/10.1016/j.euroneuro.2019.06.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31255396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Neuropsychopharmacol&amp;title=Novel%20antipsychotics%20specificity%20profile:%20A%20clinically%20oriented%20review%20of%20lurasidone,%20brexpiprazole,%20cariprazine%20and%20lumateperone&amp;author=F%20Corponi&amp;author=C%20Fabbri&amp;author=I%20Bitter&amp;author=S%20Montgomery&amp;author=E%20Vieta&amp;volume=29&amp;issue=9&amp;publication_year=2019&amp;pages=971-85&amp;pmid=31255396&amp;doi=10.1016/j.euroneuro.2019.06.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref022">
<span class="label">22.</span><cite>Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry. 2000;57(11):1012–30. doi: 10.1001/archpsyc.57.11.1012

</cite> [<a href="https://doi.org/10.1001/archpsyc.57.11.1012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11074867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Gen%20Psychiatry&amp;title=The%20neurobiology%20of%20sexual%20function&amp;author=CM%20Meston&amp;author=PF%20Frohlich&amp;volume=57&amp;issue=11&amp;publication_year=2000&amp;pages=1012-30&amp;pmid=11074867&amp;doi=10.1001/archpsyc.57.11.1012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref023">
<span class="label">23.</span><cite>Mohr P, Masopust J, Kopeček M. Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?
Front Psychiatry. 2022;12:781946. doi: 10.3389/fpsyt.2021.781946

</cite> [<a href="https://doi.org/10.3389/fpsyt.2021.781946" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8821167/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35145438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Psychiatry&amp;title=Dopamine%20Receptor%20Partial%20Agonists:%20Do%20They%20Differ%20in%20Their%20Clinical%20Efficacy?&amp;author=P%20Mohr&amp;author=J%20Masopust&amp;author=M%20Kope%C4%8Dek&amp;volume=12&amp;publication_year=2022&amp;pages=781946&amp;pmid=35145438&amp;doi=10.3389/fpsyt.2021.781946&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref024">
<span class="label">24.</span><cite>Kikuchi T, Maeda K, Suzuki M, Hirose T, Futamura T, McQuade RD. Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole. Neuropsychopharmacol Rep. 2021;41(2):134–43. doi: 10.1002/npr2.12180

</cite> [<a href="https://doi.org/10.1002/npr2.12180" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8340839/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33960741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacol%20Rep&amp;title=Discovery%20research%20and%20development%20history%20of%20the%20dopamine%20D2%20receptor%20partial%20agonists,%20aripiprazole%20and%20brexpiprazole&amp;author=T%20Kikuchi&amp;author=K%20Maeda&amp;author=M%20Suzuki&amp;author=T%20Hirose&amp;author=T%20Futamura&amp;volume=41&amp;issue=2&amp;publication_year=2021&amp;pages=134-43&amp;pmid=33960741&amp;doi=10.1002/npr2.12180&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref025">
<span class="label">25.</span><cite>Laszlovszky I, Barabássy Á, Németh G. Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety. Adv Ther. 2021;38(7):3652–73. doi: 10.1007/s12325-021-01797-5

</cite> [<a href="https://doi.org/10.1007/s12325-021-01797-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8279990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34091867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Ther&amp;title=Cariprazine,%20A%20Broad-Spectrum%20Antipsychotic%20for%20the%20Treatment%20of%20Schizophrenia:%20Pharmacology,%20Efficacy,%20and%20Safety&amp;author=I%20Laszlovszky&amp;author=%C3%81%20Barab%C3%A1ssy&amp;author=G%20N%C3%A9meth&amp;volume=38&amp;issue=7&amp;publication_year=2021&amp;pages=3652-73&amp;pmid=34091867&amp;doi=10.1007/s12325-021-01797-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref026">
<span class="label">26.</span><cite>Citrome L. Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic. Clin Schizophr Relat Psychoses. 2011;4(4):251–7. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/21177242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Schizophr%20Relat%20Psychoses&amp;title=Lurasidone%20for%20schizophrenia:%20a%20brief%20review%20of%20a%20new%20second-generation%20antipsychotic&amp;author=L%20Citrome&amp;volume=4&amp;issue=4&amp;publication_year=2011&amp;pages=251-7&amp;pmid=21177242&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref027">
<span class="label">27.</span><cite>Keks N, Hope J, Schwartz D, McLennan H, Copolov D, Meadows G. Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia. CNS Drugs. 2020;34(5):473–507. doi: 10.1007/s40263-020-00718-4

</cite> [<a href="https://doi.org/10.1007/s40263-020-00718-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32246399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CNS%20Drugs&amp;title=Comparative%20Tolerability%20of%20Dopamine%20D2/3%20Receptor%20Partial%20Agonists%20for%20Schizophrenia&amp;author=N%20Keks&amp;author=J%20Hope&amp;author=D%20Schwartz&amp;author=H%20McLennan&amp;author=D%20Copolov&amp;volume=34&amp;issue=5&amp;publication_year=2020&amp;pages=473-507&amp;pmid=32246399&amp;doi=10.1007/s40263-020-00718-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref028">
<span class="label">28.</span><cite>Leeman LM, Rogers RG. Sex after childbirth: postpartum sexual function. Obstet Gynecol. 2012;119(3):647–55. doi: 10.1097/AOG.0b013e3182479611

</cite> [<a href="https://doi.org/10.1097/AOG.0b013e3182479611" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22353966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Obstet%20Gynecol&amp;title=Sex%20after%20childbirth:%20postpartum%20sexual%20function&amp;author=LM%20Leeman&amp;author=RG%20Rogers&amp;volume=119&amp;issue=3&amp;publication_year=2012&amp;pages=647-55&amp;pmid=22353966&amp;doi=10.1097/AOG.0b013e3182479611&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref029">
<span class="label">29.</span><cite>Hunt GE, Large MM, Cleary M, Lai HMX, Saunders JB. Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: systematic review and meta-analysis. Drug Alcohol Depend. 2018;191:234–58.
</cite> [<a href="https://doi.org/10.1016/j.drugalcdep.2018.07.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30153606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Alcohol%20Depend&amp;title=Prevalence%20of%20comorbid%20substance%20use%20in%20schizophrenia%20spectrum%20disorders%20in%20community%20and%20clinical%20settings,%201990-2017:%20systematic%20review%20and%20meta-analysis&amp;author=GE%20Hunt&amp;author=MM%20Large&amp;author=M%20Cleary&amp;author=HMX%20Lai&amp;author=JB%20Saunders&amp;volume=191&amp;publication_year=2018&amp;pages=234-58&amp;pmid=30153606&amp;doi=10.1016/j.drugalcdep.2018.07.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref030">
<span class="label">30.</span><cite>de Boer MK, Castelein S, Wiersma D, Schoevers RA, Knegtering H. A systematic review of instruments to measure sexual functioning in patients using antipsychotics. J Sex Res. 2014;51(4):383–9.
</cite> [<a href="https://doi.org/10.1080/00224499.2013.865111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24754359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Sex%20Res&amp;title=A%20systematic%20review%20of%20instruments%20to%20measure%20sexual%20functioning%20in%20patients%20using%20antipsychotics&amp;author=MK%20de%20Boer&amp;author=S%20Castelein&amp;author=D%20Wiersma&amp;author=RA%20Schoevers&amp;author=H%20Knegtering&amp;volume=51&amp;issue=4&amp;publication_year=2014&amp;pages=383-9&amp;pmid=24754359&amp;doi=10.1080/00224499.2013.865111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref031">
<span class="label">31.</span><cite>Pagana KDPT, Pagana TN. Mosby’s Diagnostic &amp; Laboratory Test Reference. 17 edition. St. Louis: Elsevier. 2025.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Mosby%E2%80%99s%20Diagnostic%20&amp;%20Laboratory%20Test%20Reference&amp;author=KDPT%20Pagana&amp;author=TN%20Pagana&amp;publication_year=2025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref032">
<span class="label">32.</span><cite>Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N. Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol. 2005;20(1):49–52. doi: 10.1097/00004850-200501000-00010

</cite> [<a href="https://doi.org/10.1097/00004850-200501000-00010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15602117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Clin%20Psychopharmacol&amp;title=Imputing%20response%20rates%20from%20means%20and%20standard%20deviations%20in%20meta-analyses&amp;author=TA%20Furukawa&amp;author=A%20Cipriani&amp;author=C%20Barbui&amp;author=P%20Brambilla&amp;author=N%20Watanabe&amp;volume=20&amp;issue=1&amp;publication_year=2005&amp;pages=49-52&amp;pmid=15602117&amp;doi=10.1097/00004850-200501000-00010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref033">
<span class="label">33.</span><cite>Levin RJ. Critically revisiting aspects of the human sexual response cycle of Masters and Johnson: correcting errors and suggesting modifications. Sex Relation Ther. 2008;23(4):393–9.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Sex%20Relation%20Ther&amp;title=Critically%20revisiting%20aspects%20of%20the%20human%20sexual%20response%20cycle%20of%20Masters%20and%20Johnson:%20correcting%20errors%20and%20suggesting%20modifications&amp;author=RJ%20Levin&amp;volume=23&amp;issue=4&amp;publication_year=2008&amp;pages=393-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref034">
<span class="label">34.</span><cite>Furukawa TA, Salanti G, Atkinson LZ, Leucht S, Ruhe HG, Turner EH, et al. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. BMJ Open. 2016;6(7):e010919. doi: 10.1136/bmjopen-2015-010919

</cite> [<a href="https://doi.org/10.1136/bmjopen-2015-010919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4947714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27401359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open&amp;title=Comparative%20efficacy%20and%20acceptability%20of%20first-generation%20and%20second-generation%20antidepressants%20in%20the%20acute%20treatment%20of%20major%20depression:%20protocol%20for%20a%20network%20meta-analysis&amp;author=TA%20Furukawa&amp;author=G%20Salanti&amp;author=LZ%20Atkinson&amp;author=S%20Leucht&amp;author=HG%20Ruhe&amp;volume=6&amp;issue=7&amp;publication_year=2016&amp;pmid=27401359&amp;doi=10.1136/bmjopen-2015-010919&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref035">
<span class="label">35.</span><cite>Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol. 2006;59(1):7–10. doi: 10.1016/j.jclinepi.2005.06.006

</cite> [<a href="https://doi.org/10.1016/j.jclinepi.2005.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16360555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Epidemiol&amp;title=Imputing%20missing%20standard%20deviations%20in%20meta-analyses%20can%20provide%20accurate%20results&amp;author=TA%20Furukawa&amp;author=C%20Barbui&amp;author=A%20Cipriani&amp;author=P%20Brambilla&amp;author=N%20Watanabe&amp;volume=59&amp;issue=1&amp;publication_year=2006&amp;pages=7-10&amp;pmid=16360555&amp;doi=10.1016/j.jclinepi.2005.06.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref036">
<span class="label">36.</span><cite>Higgins JPTT, J CJ, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions. 2 ed. Chichester (UK): John Wiley &amp; Sons; 2019.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Cochrane%20Handbook%20for%20Systematic%20Reviews%20of%20Interventions&amp;author=JPTT%20Higgins&amp;author=CJ%20J&amp;author=M%20Cumpston&amp;author=T%20Li&amp;author=MJ%20Page&amp;publication_year=2019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref037">
<span class="label">37.</span><cite>Hamer RM, Simpson PM. Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials. Am J Psychiatry. 2009;166(6):639–41. doi: 10.1176/appi.ajp.2009.09040458

</cite> [<a href="https://doi.org/10.1176/appi.ajp.2009.09040458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19487398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Psychiatry&amp;title=Last%20observation%20carried%20forward%20versus%20mixed%20models%20in%20the%20analysis%20of%20psychiatric%20clinical%20trials&amp;author=RM%20Hamer&amp;author=PM%20Simpson&amp;volume=166&amp;issue=6&amp;publication_year=2009&amp;pages=639-41&amp;pmid=19487398&amp;doi=10.1176/appi.ajp.2009.09040458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref038">
<span class="label">38.</span><cite>Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898

</cite> [<a href="https://doi.org/10.1136/bmj.l4898" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31462531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=RoB%202:%20a%20revised%20tool%20for%20assessing%20risk%20of%20bias%20in%20randomised%20trials&amp;author=JAC%20Sterne&amp;author=J%20Savovi%C4%87&amp;author=MJ%20Page&amp;author=RG%20Elbers&amp;author=NS%20Blencowe&amp;volume=366&amp;publication_year=2019&amp;pmid=31462531&amp;doi=10.1136/bmj.l4898&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref039">
<span class="label">39.</span><cite>Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol. 2012;41(3):818–27. doi: 10.1093/ije/dys041

</cite> [<a href="https://doi.org/10.1093/ije/dys041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3396310/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22461129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Epidemiol&amp;title=Predicting%20the%20extent%20of%20heterogeneity%20in%20meta-analysis,%20using%20empirical%20data%20from%20the%20Cochrane%20Database%20of%20Systematic%20Reviews&amp;author=RM%20Turner&amp;author=J%20Davey&amp;author=MJ%20Clarke&amp;author=SG%20Thompson&amp;author=JP%20Higgins&amp;volume=41&amp;issue=3&amp;publication_year=2012&amp;pages=818-27&amp;pmid=22461129&amp;doi=10.1093/ije/dys041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref040">
<span class="label">40.</span><cite>Rhodes KM, Turner RM, Higgins JPT. Empirical evidence about inconsistency among studies in a pair-wise meta-analysis. Res Synth Methods. 2016;7(4):346–70. doi: 10.1002/jrsm.1193

</cite> [<a href="https://doi.org/10.1002/jrsm.1193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5217093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26679486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Res%20Synth%20Methods&amp;title=Empirical%20evidence%20about%20inconsistency%20among%20studies%20in%20a%20pair-wise%20meta-analysis&amp;author=KM%20Rhodes&amp;author=RM%20Turner&amp;author=JPT%20Higgins&amp;volume=7&amp;issue=4&amp;publication_year=2016&amp;pages=346-70&amp;pmid=26679486&amp;doi=10.1002/jrsm.1193&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref041">
<span class="label">41.</span><cite>Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80–97. doi: 10.1002/jrsm.1037

</cite> [<a href="https://doi.org/10.1002/jrsm.1037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26062083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Res%20Synth%20Methods&amp;title=Indirect%20and%20mixed-treatment%20comparison,%20network,%20or%20multiple-treatments%20meta-analysis:%20many%20names,%20many%20benefits,%20many%20concerns%20for%20the%20next%20generation%20evidence%20synthesis%20tool&amp;author=G%20Salanti&amp;volume=3&amp;issue=2&amp;publication_year=2012&amp;pages=80-97&amp;pmid=26062083&amp;doi=10.1002/jrsm.1037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref042">
<span class="label">42.</span><cite>Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7–8):932–44. doi: 10.1002/sim.3767

</cite> [<a href="https://doi.org/10.1002/sim.3767" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20213715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stat%20Med&amp;title=Checking%20consistency%20in%20mixed%20treatment%20comparison%20meta-analysis&amp;author=S%20Dias&amp;author=NJ%20Welton&amp;author=DM%20Caldwell&amp;author=AE%20Ades&amp;volume=29&amp;publication_year=2010&amp;pages=932-44&amp;pmid=20213715&amp;doi=10.1002/sim.3767&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref043">
<span class="label">43.</span><cite>Hofer A, Hummer M, Huber R, Kurz M, Walch T, Fleischhacker WW. Selection bias in clinical trials with antipsychotics. J Clin Psychopharmacol. 2000;20(6):699–702. doi: 10.1097/00004714-200012000-00019

</cite> [<a href="https://doi.org/10.1097/00004714-200012000-00019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11106145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Psychopharmacol&amp;title=Selection%20bias%20in%20clinical%20trials%20with%20antipsychotics&amp;author=A%20Hofer&amp;author=M%20Hummer&amp;author=R%20Huber&amp;author=M%20Kurz&amp;author=T%20Walch&amp;volume=20&amp;issue=6&amp;publication_year=2000&amp;pages=699-702&amp;pmid=11106145&amp;doi=10.1097/00004714-200012000-00019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref044">
<span class="label">44.</span><cite>Chiocchia V, Nikolakopoulou A, Higgins JPT, Page MJ, Papakonstantinou T, Cipriani A, et al. ROB-MEN: a tool to assess risk of bias due to missing evidence in network meta-analysis. BMC Med. 2021;19(1):304. doi: 10.1186/s12916-021-02166-3

</cite> [<a href="https://doi.org/10.1186/s12916-021-02166-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8609747/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34809639/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med&amp;title=ROB-MEN:%20a%20tool%20to%20assess%20risk%20of%20bias%20due%20to%20missing%20evidence%20in%20network%20meta-analysis&amp;author=V%20Chiocchia&amp;author=A%20Nikolakopoulou&amp;author=JPT%20Higgins&amp;author=MJ%20Page&amp;author=T%20Papakonstantinou&amp;volume=19&amp;issue=1&amp;publication_year=2021&amp;pages=304&amp;pmid=34809639&amp;doi=10.1186/s12916-021-02166-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329559.ref045">
<span class="label">45.</span><cite>Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JPT. Evaluating the quality of evidence from a network meta-analysis. PLoS One. 2014;9(7):e99682. doi: 10.1371/journal.pone.0099682

</cite> [<a href="https://doi.org/10.1371/journal.pone.0099682" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4084629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24992266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Evaluating%20the%20quality%20of%20evidence%20from%20a%20network%20meta-analysis&amp;author=G%20Salanti&amp;author=C%20Del%20Giovane&amp;author=A%20Chaimani&amp;author=DM%20Caldwell&amp;author=JPT%20Higgins&amp;volume=9&amp;issue=7&amp;publication_year=2014&amp;pmid=24992266&amp;doi=10.1371/journal.pone.0099682&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="pone.0329559.r001"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0329559.r001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329559.r001</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 0</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamasaki%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Hidetaka Hamasaki</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Hidetaka Hamasaki</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamasaki%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hidetaka Hamasaki</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Hidetaka Hamasaki</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.c" class="d-panel p" style="display: none">
<div>© 2025 Hidetaka Hamasaki</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>19 May 2025</em>
</p>
<p>PONE-D-25-05627Sexual difficulty related to use of antipsychotics: a protocol for systematic review and meta-analysisPLOS ONE</p>
<p>Dear Dr. Herder,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Jul 03 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span> . When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a> .</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Hidetaka Hamasaki</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
<p><a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and</p>
<p>
<a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a>
</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?</p>
<p>The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?</p>
<p>The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.</p>
<p>Reviewer #1: Partly</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: Partly</p>
<p>**********</p>
<p>3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?</p>
<p>Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>4. Have the authors described where all data underlying the findings will be made available when the study is complete?</p>
<p>The <a href="https://journals.plos.org/plosone/s/materials-and-software-sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.</p>
<p>You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.</p>
<p>(Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #1: This manuscript presents a protocol for a systematic review and meta-analysis investigating the association between antipsychotic use and sexual dysfunction. Given the significant impact of sexual dysfunction on treatment adherence and quality of life, this study aims to provide a comprehensive synthesis of existing evidence, comparing different antipsychotic medications.</p>
<p>Below are my specific comments:</p>
<p>1. Inclusion of Open-Label Trials</p>
<p>• The inclusion of open-label trials raises concerns about potential bias, particularly given the subjective nature of sexual dysfunction assessments. Unblinded studies may lead to over- or underreporting of symptoms due to patient and clinician expectations. The authors should clarify their rationale for including open-label trials and discuss whether any sensitivity analyses are planned to assess their impact on the findings.</p>
<p>2. Confounding Effects of Psychiatric Diagnoses</p>
<p>• The protocol includes patients with bipolar disorder and major depressive disorder, both of which can independently influence sexual function. While the authors plan subgroup analyses based on concomitant antidepressant use, it is unclear whether stratification or adjustments for psychiatric diagnoses are planned. Clarifying how the study will account for these confounding effects would strengthen the methodology.</p>
<p>3. Consistency in Study Inclusion Criteria</p>
<p>• The description of included study designs differs between the Abstract and Methods sections. In the Abstract, the authors state that both “controlled and uncontrolled randomized trials” will be included, while in the Methods, they specify “only blinded and open randomized controlled trials.” If the intention is to include only RCTs, the wording in the Abstract should be clarified to avoid potential confusion regarding whether non-controlled trials are eligible.</p>
<p>Reviewer #2: You have obtained many results. Write a conclusion based on these results, in a broad manner.</p>
<p>Thank you</p>
<p>Reviewer #3: Introduction:</p>
<p>- Clarify how the current review differs from the 2011 meta-analysis in terms of scope, the inclusion of newer antipsychotic drugs, and updated research findings.</p>
<p>- Include a clear, operational definition of "sexual dysfunction," as it is central to the focus of the review.</p>
<p>- Report available prevalence statistics of sexual dysfunction among patients taking antipsychotics to highlight its clinical importance.</p>
<p>- Provide brief explanations of terms such as hyperprolactinemia and dopamine antagonists to ensure accessibility for interdisciplinary readers, especially those from behavioral sciences and therapy-based backgrounds.</p>
<p>Methodology:</p>
<p>- Define “primary mental health disorder” with an operational definition and clarify which psychiatric conditions are included. Although diagnoses are mentioned, it is not clearly specified what is meant by “primary mental health disorder” in the context of the study.</p>
<p>- Specify whether the study accounts for the duration of antipsychotic use in inclusion or exclusion criteria.</p>
<p>- Indicate if the study considers or stratifies participants based on gender, given its relevance to sexual dysfunction.</p>
<p>- Clearly define the inclusion and exclusion criteria in terms of age, gender, and specific diagnoses.</p>
<p>- Justify the inclusion of serum prolactin as an outcome variable and explain its role as a physiological correlate of sexual dysfunction.</p>
<p>Exclusion Criteria:</p>
<p>- Clarify whether neurological conditions, substance use disorders, hypogonadism, and androgen disorders are explicitly excluded, and if they are not already captured under "somatic diseases."</p>
<p>Search Strategy:</p>
<p>- Mention if MeSH terms will be used in the systematic search strategy to ensure thorough and standardized literature retrieval.</p>
<p>Data Extraction and Analysis:</p>
<p>- Recommend including variables such as sample size per study, treatment or follow-up duration, and sex/gender distribution in the descriptive statistics to enhance the comprehensiveness of the analysis.</p>
<p>Discussion:</p>
<p>- Strengthen the rationale by clearly linking how the findings could influence clinical decisions, improve adherence to antipsychotic treatment, and guide future intervention strategies.</p>
<p>Reviewer #4: The submitted manuscript outlines a protocol for a systematic review and network meta-analysis investigating the prevalence and characteristics of sexual dysfunction associated with antipsychotic medication use.</p>
<p>The review plans to assess both the overall prevalence and specific domains (desire, arousal, orgasm), as well as the role of prolactin levels. The protocol is methodologically well-structured, with PROSPERO registration, PRISMA-P adherence, and use of rob 2 and GRADE frameworks, ensuring transparency and robustness. This topic is highly relevant due to the significant clinical impact of sexual side effects on treatment adherence, quality of life, and patient well-being.</p>
<p>The manuscript is clear in its aim, methodology, and expected outcomes. However, several key areas could be strengthened to enhance its methodological rigor, analytical depth, and clinical relevance.</p>
<p>1.Inclusion Criteria and Data Sources</p>
<p>The protocol excludes studies using semi-structured interviews or non-validated tools, focusing only on standardized questionnaires. While this increases internal validity, it risks excluding clinically meaningful data, especially qualitative insights.</p>
<p>Recommendation: Consider adding a sensitivity analysis including studies with semi-structured interviews or discuss this limitation more explicitly. You might also explore incorporating grey literature systematically (e.g., OpenGrey, ProQuest Dissertations) to mitigate publication bias.</p>
<p>2.Translation of Non-English Articles – Line 172-213</p>
<p>The authors plan to use ChatGPT 4.0 for machine translation of articles. This raises concerns about translation accuracy and loss of nuance.</p>
<p>Recommendation: Provide a clear quality control plan, e.g., using back-translation or secondary human verification, especially for key methodological sections.</p>
<p>3.Handling Missing Data</p>
<p>The protocol outlines the use of Furukawas method for imputing response rates, which is valid under certain assumptions.</p>
<p>Recommendation: Clarify the assumptions under which this method will be applied and plan sensitivity analyses to test robustness with and without imputed data.</p>
<p>4.Transitivity and Effect Modifiers in NMA</p>
<p>Although the authors mention assessing transitivity, the specific clinical and methodological effect modifiers are not clearly listed.</p>
<p>Recommendation: Explicitly describe variables (e.g., baseline sexual function, diagnosis, age, gender, medications, dosage) that will be evaluated to ensure comparability across trials.</p>
<p>5.Subgroup Analyses and Meta-Regression</p>
<p>Subgroup and metaregression analyses are briefly mentioned.</p>
<p>Recommendation: Specify the exact variables to be included, criteria for inclusion (e.g., minimum number of studies), and how multicollinearity will be managed.</p>
<p>6.Potential Bias and Publication Bias</p>
<p>While funnel plots and selection models are planned, no mention is made of bias introduced by industry sponsorship or selective reporting.</p>
<p>Recommendation: Include plans to evaluate sponsorship bias explicitly and consider including funding sources as a moderator in metaregression.</p>
<p>7.Implementation in Clinical Practice</p>
<p>The discussion touches on shared decision-making but lacks details on how results will translate to practice.</p>
<p>Recommendation: Expand the discussion on how the findings could inform treatment guidelines, shared decision-making tools, or clinical decision support systems.</p>
<p>Minor Comments</p>
<p>1.Typographical Errors</p>
<p>Line 36: "prolactin levels land sexual dysfunction" should be "and sexual dysfunction."</p>
<p>Multiple minor grammatical errors (e.g., "Antipsychotics are thought affect" should be "thought to affect").</p>
<p>Recommendation: A thorough language check is recommended to improve clarity.</p>
<p>2.Figure and Supplementary Materials</p>
<p>Ensure that Figure 1 (decision-tree) and supplementary files (search strategy, PRISMA-P checklist) are well-integrated and referenced properly in the main text.</p>
<p>3.References</p>
<p>The reference list is up-to-date and balanced; however, maybe these could enrich the discussion:</p>
<p>Clayton, A. H., &amp; Montejo, A. L. (2014). Major depressive disorder, antidepressants, and sexual dysfunction. Journal of Clinical Psychiatry, 75(4), 383–391. <a href="https://doi.org/10.4088/JCP.13com13629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.4088/JCP.13com13629</a></p>
<p>and this</p>
<p>Ebrahim, S., Akl, E. A., Mustafa, R. A., Sun, X., Walter, S. D., &amp; Heels-Ansdell, D. (2013). Addressing continuous data measured with different instruments for outcome synthesis in systematic reviews: A survey of current practice and methods. Systematic Reviews, 2, Article 70. <a href="https://doi.org/10.1186/2046-4053-2-70" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1186/2046-4053-2-70</a></p>
<p>**********</p>
<p>7. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a> .</p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: No</p>
<p>Reviewer #3: No</p>
<p>Reviewer #4: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span> . Please note that Supporting Information files do not need this step.</p>
<section class="sm xbox font-sm" id="pone.0329559.s003"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Recommendations_AK.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s003.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s003.docx</a><sup> (16.5KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0329559.r002"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2025 Aug 21;20(8):e0329559. doi: <a href="https://doi.org/10.1371/journal.pone.0329559.r002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329559.r002</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 1</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.d" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.d" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.d" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub2" class="history"><p>Collection date 2025.</p></section></div></div>
<div id="clp_a.d" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>19 Jun 2025</em>
</p>
<p>We thank the reviewers for their valuable comments and suggestions. Please find our detailed responses and revisions in the accompanying rebuttal letter.</p>
<section class="sm xbox font-sm" id="pone.0329559.s005"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s005.docx</a><sup> (59.5KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0329559.r003"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0329559.r003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329559.r003</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 1</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamasaki%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Hidetaka Hamasaki</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Hidetaka Hamasaki</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamasaki%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hidetaka Hamasaki</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.e" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.e" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.e" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Hidetaka Hamasaki</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.e" class="d-panel p" style="display: none">
<div>© 2025 Hidetaka Hamasaki</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>1 Jul 2025</em>
</p>
<p>PONE-D-25-05627R1Sexual difficulty related to use of antipsychotics: a protocol for systematic review and meta-analysisPLOS ONE</p>
<p>Dear Dr. Herder,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Aug 15 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span> . When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a> .</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Hidetaka Hamasaki</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?</p>
<p>The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?</p>
<p>The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?</p>
<p>Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>4. Have the authors described where all data underlying the findings will be made available when the study is complete?</p>
<p>The <a href="https://journals.plos.org/plosone/s/materials-and-software-sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.</p>
<p>You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.</p>
<p>(Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #4: Thank you for thoroughly addressing previous major revision requests. The current manuscript is a substantial improvement, with clearer inclusion/exclusion criteria (particularly regarding the focus on validated sexual dysfunction questionnaires), an expanded and rigorous statistical analysis plan, and transparent plans for bias and transitivity assessments in NMA.</p>
<p>Specific strengths:</p>
<p>- The inclusion of a broad set of antipsychotics, including newer agents like aripiprazole, brexpiprazole, and cariprazine, which is clinically relevant.</p>
<p>- Comprehensive strategy for subgroup and sensitivity analyses, which increases the robustness of findings.</p>
<p>- The plan to handle language barriers in studies using machine translation followed by verification demonstrates thoughtful planning.</p>
<p>Minor recommendations:</p>
<p>- Ensure consistent use of terms: e.g., there are instances of “sexual difficulties” vs. “sexual dysfunction”, using one term throughout would improve clarity.</p>
<p>- In the introduction, the authors mention “sexual difficulties” affecting the “specific phases of sexual function”; consider clarifying early that this refers to desire, arousal, and orgasm to set context.</p>
<p>- Double-check minor typographical issues like “land sexual dysfunction” in the abstract (should be “and sexual dysfunction”).</p>
<p>Overall, I believe the manuscript is now technically sound, methodologically rigorous, and suitable for publication upon addressing these minor points.</p>
<p>**********</p>
<p>7. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a> .</p>
<p>Reviewer #4: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span> . Please note that Supporting Information files do not need this step.</p></section></article><article class="sub-article" id="pone.0329559.r004"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2025 Aug 21;20(8):e0329559. doi: <a href="https://doi.org/10.1371/journal.pone.0329559.r004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329559.r004</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 2</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.f" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.f" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.f" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub4" class="history"><p>Collection date 2025.</p></section></div></div>
<div id="clp_a.f" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>4 Jul 2025</em>
</p>
<p>See attachment 'Response to reviewers (second revision)'</p>
<section class="sm xbox font-sm" id="pone.0329559.s006"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers (second revision).docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s006.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s006.docx</a><sup> (20.1KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0329559.r005"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0329559.r005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329559.r005</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 2</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamasaki%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Hidetaka Hamasaki</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Hidetaka Hamasaki</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamasaki%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hidetaka Hamasaki</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.g" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.g" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.g" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Hidetaka Hamasaki</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.g" class="d-panel p" style="display: none">
<div>© 2025 Hidetaka Hamasaki</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>18 Jul 2025</em>
</p>
<p>Sexual dysfunctions related to use of antipsychotics: a protocol for systematic review and meta-analysis</p>
<p>PONE-D-25-05627R2</p>
<p>Dear Dr. Herder,</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Editorial Manager®</a>  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>Kind regards,</p>
<p>Hidetaka Hamasaki</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Additional Editor Comments (optional):</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?</p>
<p>The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?</p>
<p>The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?</p>
<p>Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>4. Have the authors described where all data underlying the findings will be made available when the study is complete?</p>
<p>The <a href="https://journals.plos.org/plosone/s/materials-and-software-sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.</p>
<p>You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.</p>
<p>(Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #4: The revised protocol is well constructed, clearly presented, and methodologically rigorous. The authors have responded adequately to prior reviewer suggestions, including clarifying their statistical analysis strategy and enhancing discussion of sex/gender considerations.</p>
<p>Some optional suggestions to consider in final planning:</p>
<p>- In the limitations section, you may wish to explicitly reflect on the expected heterogeneity of reporting sexual dysfunction across studies (e.g., variability in definitions and outcome measures).</p>
<p>- Consider making the plan for narrative synthesis more concrete, especially in case meta-analysis proves infeasible due to study heterogeneity.</p>
<p>- If possible, include an example search string in the supplementary material to enhance reproducibility for future researchers.</p>
<p>Overall, this protocol meets high methodological standards and addresses an important clinical issue. I look forward to seeing the findings.</p>
<p>**********</p>
<p>7. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a> .</p>
<p>Reviewer #4: No</p>
<p>**********</p></section></article><article class="sub-article" id="pone.0329559.r006"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0329559.r006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329559.r006</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Acceptance letter</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamasaki%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Hidetaka Hamasaki</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Hidetaka Hamasaki</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamasaki%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hidetaka Hamasaki</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.h" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.h" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.h" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Hidetaka Hamasaki</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.h" class="d-panel p" style="display: none">
<div>© 2025 Hidetaka Hamasaki</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>PONE-D-25-05627R2</p>
<p>PLOS ONE</p>
<p>Dear Dr. Herder,</p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p>
<p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p>
<p>* All references, tables, and figures are properly cited</p>
<p>* All relevant supporting information is included in the manuscript submission,</p>
<p>* There are no issues that prevent the paper from being properly typeset</p>
<p>You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.</p>
<p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at <a href="https://explore.plos.org/phishing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://explore.plos.org/phishing</a>.</p>
<p>If we can help with anything else, please email us at customercare@plos.org.</p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access.</p>
<p>Kind regards,</p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Dr. Hidetaka Hamasaki</p>
<p>Academic Editor</p>
<p>PLOS ONE</p></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 File. PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s001.pdf</a><sup> (101KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S1 Appendix. Search terms for study screening.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s002.pdf</a><sup> (661.8KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Recommendations_AK.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s003.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s003.docx</a><sup> (16.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s005.docx</a><sup> (59.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers (second revision).docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370141/bin/pone.0329559.s006.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329559.s006.docx</a><sup> (20.1KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0329559"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0329559.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (453.4 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12370141/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12370141/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370141%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370141/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12370141/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12370141/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40839626/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12370141/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40839626/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12370141/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12370141/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="mCRedCPUtAuRniib9iZMKLD5Oc0oTRhDRLnHmUzuBIdTynutVWtc5uCPVbME7vZH">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
